These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10391094)

  • 1. Reduction of end-stage malignant glioma by injection with autologous cytotoxic T lymphocytes.
    Tsurushima H; Liu SQ; Tuboi K; Matsumura A; Yoshii Y; Nose T; Saijo K; Ohno T
    Jpn J Cancer Res; 1999 May; 90(5):536-45. PubMed ID: 10391094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of specific cytotoxic T lymphocytes against autologous brain tumor by crossreactive allo-tumor cell stimulation.
    Saitoh S; Kurisaka M; Mori K; Maeda N; Fujimoto S
    Jpn J Cancer Res; 1997 Mar; 88(3):289-95. PubMed ID: 9140114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma.
    Brown CE; Badie B; Barish ME; Weng L; Ostberg JR; Chang WC; Naranjo A; Starr R; Wagner J; Wright C; Zhai Y; Bading JR; Ressler JA; Portnow J; D'Apuzzo M; Forman SJ; Jensen MC
    Clin Cancer Res; 2015 Sep; 21(18):4062-72. PubMed ID: 26059190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor.
    Montagna D; Turin I; Schiavo R; Montini E; Zaffaroni N; Villa R; Secondino S; Schiavetto I; Caliogna L; Locatelli F; Libri V; Pession A; Tonelli R; Maccario R; Siena S; Pedrazzoli P
    Cytotherapy; 2012 Jan; 14(1):80-90. PubMed ID: 21942841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2.
    Kruse CA; Cepeda L; Owens B; Johnson SD; Stears J; Lillehei KO
    Cancer Immunol Immunother; 1997 Oct; 45(2):77-87. PubMed ID: 9390198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.
    Yu JS; Liu G; Ying H; Yong WH; Black KL; Wheeler CJ
    Cancer Res; 2004 Jul; 64(14):4973-9. PubMed ID: 15256471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of apoptosis in normal ontogenesis and solid human neoplasms.
    Kaiser HE; Bodey B
    In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of local injection of ex vivo expanded autologous tumor-specific T lymphocytes in cases with recurrent malignant gliomas.
    Tsuboi K; Saijo K; Ishikawa E; Tsurushima H; Takano S; Morishita Y; Ohno T
    Clin Cancer Res; 2003 Aug; 9(9):3294-302. PubMed ID: 12960115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma.
    Yamanaka R; Honma J; Tsuchiya N; Yajima N; Kobayashi T; Tanaka R
    J Neurooncol; 2005 Apr; 72(2):107-13. PubMed ID: 15925989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell adoptive immunotherapy of newly diagnosed gliomas.
    Plautz GE; Miller DW; Barnett GH; Stevens GH; Maffett S; Kim J; Cohen PA; Shu S
    Clin Cancer Res; 2000 Jun; 6(6):2209-18. PubMed ID: 10873070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia.
    Turin I; Pedrazzoli P; Tullio C; Montini E; La Grotteria MC; Schiavo R; Perotti C; Locatelli F; Carretto E; Maccario R; Siena S; Montagna D
    Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with grade III/IV astrocytoma.
    Holladay FP; Heitz-Turner T; Bayer WL; Wood GW
    J Neurooncol; 1996 Feb; 27(2):179-89. PubMed ID: 8699241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.
    Durgeau A; Virk Y; Corgnac S; Mami-Chouaib F
    Front Immunol; 2018; 9():14. PubMed ID: 29403496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course and immune response of a renal cell carcinoma patient to adoptive transfer of autologous cytotoxic T lymphocytes.
    Kawai K; Saijo K; Oikawa T; Morishita Y; Noguchi M; Ohno T; Akaza H
    Clin Exp Immunol; 2003 Nov; 134(2):264-9. PubMed ID: 14616786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of human autologous cytotoxic T lymphocytes against minced tissues of glioblastoma multiforme.
    Tsurushima H; Liu SQ; Tsuboi K; Yoshii Y; Nose T; Ohno T
    J Neurosurg; 1996 Feb; 84(2):258-63. PubMed ID: 8592229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells.
    Kahlon KS; Brown C; Cooper LJ; Raubitschek A; Forman SJ; Jensen MC
    Cancer Res; 2004 Dec; 64(24):9160-6. PubMed ID: 15604287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basic and clinical study of adoptive immunotherapy using cytotoxic T lymphocyte (CTL) against cancers].
    Kitsukawa K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1448-54. PubMed ID: 2543306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics.
    Kronik N; Kogan Y; Vainstein V; Agur Z
    Cancer Immunol Immunother; 2008 Mar; 57(3):425-39. PubMed ID: 17823798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rate of induction of human autologous cytotoxic T lymphocytes against renal carcinoma cells cultured with an interleukin cocktail.
    Liu SQ; Kawai K; Shiraiwa H; Hayashi H; Akaza H; Hashizaki K; Shiba R; Saijo K; Ohno T
    Jpn J Cancer Res; 1998 Nov; 89(11):1195-201. PubMed ID: 9914789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.